5-Lipoxygenase pathway in experimental abdominal aortic aneurysms.
5-Lipoxygenase pathway in experimental abdominal aortic aneurysms.
复制标题
DOI:
10.1161/atvbaha.114.304016
复制
发表时间:
2014-12
期刊:
影响因子:
--
通讯作者:
Ailawadi G
中科院分区:
文献类型:
--
作者:
Bhamidipati CM;Whatling CA;Mehta GS;Meher AK;Hajzus VA;Su G;Salmon M;Upchurch GR Jr;Owens GK;Ailawadi G
The impact of leukotriene production by the 5-Lipoxygenase (5-LO) pathway in the pathophysiology of Abdominal Aortic Aneurysms (AAA) has been debated. Moreover, a clear mechanism through which 5-LO influences AAA remains unclear. Aneurysm formation was attenuated in 5-LO−/− mice, and in lethally irradiated WT mice reconstituted with 5-LO−/− bone marrow in an elastase perfusion model. Pharmacologic inhibition of 5-LO attenuated aneurysm formation in both aortic elastase perfused WT and angiotensin II treated LDLr−/− mice, with resultant preservation of elastin and fewer 5-LO and MMP9 producing cells. Separately, analysis of WT mice 7 days after elastase perfusion showed that 5-LO inhibition was associated with reduced polymorphonuclear leukocyte infiltration to the aortic wall. Importantly, 5-LO inhibition initiated 3 days after elastase perfusion in WT mice arrested progression of small AAA. Human AAA and control aorta corroborated these elastin and 5-LO expression patterns. Inhibition of 5-LO by pharmacologic or genetic approaches attenuates aneurysm formation and prevents fragmentation of the medial layer in two unique AAA models. Administration of 5-LO inhibitor in small AAA slows progression of AAA. Targeted interruption of the 5-LO pathway is a potential treatment strategy in AAA.